rs374898583
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_004260.4(RECQL4):c.2743A>G(p.Met915Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00002 in 1,603,604 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 10/14 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M915T) has been classified as Uncertain significance.
Frequency
Consequence
NM_004260.4 missense
Scores
Clinical Significance
Conservation
Publications
- Baller-Gerold syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: PanelApp Australia, G2P, Orphanet
- Rothmund-Thomson syndromeInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- Rothmund-Thomson syndrome type 2Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Genomics England PanelApp, G2P
- osteosarcomaInheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
- rapadilino syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000657  AC: 10AN: 152218Hom.:  0  Cov.: 34 show subpopulations 
GnomAD2 exomes  AF:  0.0000130  AC: 3AN: 231466 AF XY:  0.00000794   show subpopulations 
GnomAD4 exome  AF:  0.0000152  AC: 22AN: 1451386Hom.:  0  Cov.: 67 AF XY:  0.00000971  AC XY: 7AN XY: 721140 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000657  AC: 10AN: 152218Hom.:  0  Cov.: 34 AF XY:  0.0000672  AC XY: 5AN XY: 74360 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:2 
In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
The RECQL4 p.Met915Val variant was not identified in the literature nor was it identified in Cosmic or LOVD 3.0. The variant was identified in dbSNP (ID: rs374898583) and ClinVar (classified as uncertain significance by Invitae for Baller-Gerold syndrome). The variant was also identified in control databases in 3 of 231466 chromosomes at a frequency of 0.000013 (Genome Aggregation Database Feb 27, 2017). The variant was observed in the following populations: African in 1 of 13596 chromosomes (freq: 0.000074), Latino in 1 of 32644 chromosomes (freq: 0.000031) and European (non-Finnish) in 1 of 103854 chromosomes (freq: 0.00001), but was not observed in the Ashkenazi Jewish, East Asian, European (Finnish), Other or South Asian populations. The p.Met915 residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. -
Baller-Gerold syndrome    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at